Does TOFACITINIB Cause Lymphoproliferative disorder? 44 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Lymphoproliferative disorder have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
44
Reports of Lymphoproliferative disorder with TOFACITINIB
0.0%
of all TOFACITINIB reports
5
Deaths
20
Hospitalizations
How Dangerous Is Lymphoproliferative disorder From TOFACITINIB?
Of the 44 reports, 5 (11.4%) resulted in death, 20 (45.5%) required hospitalization, and 4 (9.1%) were considered life-threatening.
Is Lymphoproliferative disorder Listed in the Official Label?
Yes, Lymphoproliferative disorder is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Lymphoproliferative disorder?
METHOTREXATE (1,392)
INFLIXIMAB (225)
PREDNISOLONE (178)
PREDNISONE (141)
TACROLIMUS (139)
MYCOPHENOLATE MOFETIL (138)
CYCLOPHOSPHAMIDE (136)
AZATHIOPRINE (120)
ADALIMUMAB (98)
CYCLOSPORINE (98)
Which TOFACITINIB Alternatives Have Lower Lymphoproliferative disorder Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN